ORIGINAL RESEARCH

Pediatrics

doi: 10.25005/2074-0581-2025-27-2-340-349
ANTIOXIDANT STATUS AND LIPID PEROXIDATION IN HEREDITARY HEMOLYTIC ANEMIA IN CHILDREN

K.I. ISMOILOV1, M.S. KHUSENOVA1, A.M. SABUROVA2, KH.R. NASYRDZHОNOVA2

1Department of Pediatric Diseases № 2, Avicenna Tajik State Medical University, Dushanbe, Republic of Tajikistan
2Department of Biochemistry, Avicenna Tajik State Medical University, Dushanbe, Republic of Tajikistan

Objective: To examine the parameters of lipid peroxidation (LPO) and antioxidant system (AOS) in children with hereditary hemolytic anemia (HHA).

Methods: A study was conducted in the Pediatric Hematology Department of the National Medical Center "Shifobakhsh" in Dushanbe, Tajikistan, involving 60 patients diagnosed with HHA. Based on the severity of HHA, the patients were divided into three groups: 20 children (33%) with mild HHA, 23 children (39%) with moderate HHA, and 17 children (28%) with severe HHA. A control group was established, comprising 20 healthy children matched by gender and age to the study groups. For all participants, the study measured the parameters of LPO and AOS. Specific biomarkers evaluated included malonic dialdehyde (MDA), superoxide dismutase (SOD), and ascorbic acid (AA).

Results: When comparing MDA levels in children from the control group (0.58 [0.48; 0.69] μmol/l) to those in study groups based on the severity of anemia, significant differences were observed. The MDA levels were as follows: mild anemia had levels of 1.62 [1.35; 1.78] μmol/l, moderate anemia had levels of 2.14 [2.10; 2.19] μmol/l, and severe anemia had levels of 3.10 [2.95; 3.12] μmol/l, with a statistically significant difference noted (p<0.001). Furthermore, significant differences were observed when evaluating the indicators of AOS, specifically SOD and AA levels. In patients with moderate anemia, the SOD was 9.6 [9.0; 9.8] U/ml, and AA levels were 45.1 [43.3; 47.2] mmol/l. In patients with severe anemia, SOD levels were lower at 7.4 [7.2; 7.7] U/ml, and AA levels were 39.5 [39.2; 39.8] mmol/l. In comparison, patients with mild anemia had SOD levels of 15.4 [15.1; 15.7] U/ ml and AA levels of 54.6 [52.3; 58.4] mmol/l. The control group had SOD levels of 14.4 [14.2; 14.9] U/ml and AA levels of 72.8 [70.0; 74.6] mmol/l. All comparisons showed statistically significant differences (p<0.001).

Conclusion: The analysis of the study results revealed significant changes in LPO and AOS parameters, which were correlated with the severity of anemia, resulting in a worsening of the patients' condition.

Keywords: Hereditary hemolytic anemia, lipid peroxidation, antioxidant system, oxidative stress, malonic dialdehyde, superoxide dismutase, ascorbic acid.

Download file:


References
  1. Kıran T, Otlu O, Karabulut A. Oxidative stress and antioxidants in health and disease. Journal of Laboratory Medicine. 2023;47(1):1-11. https://doi. org/10.1515/labmed-2022-0108
  2. Nikitina OA, Darenskaya MA, Semyonova NV, Kolesnikova LI. Sistema antioksidantnoy zashhity: regulyatsiya metabolicheskih protsessov, geneticheskie determinanty, metody opredeleniya [Antioxidant defense system: Regulation of metabolic processes, genetic determinants, methods of determination]. Sibirskiy nauchnyy meditsinskiy zhurnal. 2022;42(3):4-17. https://doi.org/10.18699/ SSMJ20220301
  3. Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxidative Medicine and Cellular Longevity. 2014;360438:31. http://doi. org/10.1155/2014/360438
  4. Gavrilova OA. Osobennosti protsessa perekisnogo okisleniya lipidov v norme i pri nekotorykh patologicheskikh sostoyaniyakh u detey [Features of the process of lipid peroxidation in normal conditions and in some pathological conditions in children] Acta Biomedica Scientifica. 2017;4:15-9. https://doi.org/10.12737/ article_59fad50f919f18.64819381
  5. Badalova ZA, Dodkhoev JS, Saburova AM. Urovni malonovogo dial’degida i superoksiddismutazy u detey iz zony povyshennogo radiatsionnogo fona [Level of malonic dialdehyde and superoxide dismutase in children from a zone with heightened radiation background]. Vestnik Avitsenny [Avicenna Bulletin]. 2019;21(1):71-6. https://doi.org/10.25005/2074-0581-2019-21-1-71-76
  6. Belov AI, Evdokimova MV, Motina AN, Lastovskaya KV, Chertkov SV, Tiganov AR, i dr. Nasledstvennaya gemoliticheskaya anemiya, svyazannaya s defitsitom aktivnosti glyukozo-6-fosfodegidrogenazy eritrotsitov [Hereditary hemolytic anemia associated with deficiency of erythrocyte glucose-6-phosphodehydrogenase activity]. Sovremennye problemy
  7. Chesnokova NP, Morrison VV, Nevvazhay TA. Gemoliticheskie anemii, klassifikatsiya. Mekhanizmy razvitiya i gematologicheskaya kharakteristika vrozhdyonykh i nasledstvennykh gemoliticheskikh anemiy [Hemolytic anemia, classification. Developmental mechanisms and hematological characteristics of congenital and hereditary hemolytic anemia]. Mezhdunarodnyy zhurnal prikladnykh i fundamental’nykh issledovaniy. 2015;6(1):162-7.
  8. Phillips J, Henderson AC. Hemolytic anemia: Evaluation and differential diagnosis. Am Fam Physician. 2018;98(6):354-61.
  9. Martynov AI, Lukina EA, Malyavin AG. Sovremenyy vzglayd na lechenie defitsita zheleza i folievoy kisloty [Modern view on treatment of iron and folic acid deficiency]. Profilakticheskaya meditsina. 2023;26(7):80-7.
  10. Shamov IA, Gasanova PO. Zhelezo, absorbtsiya, transport [Iron, absorption, transport]. Vestnik gematologii. 2016;12(1):31-8.
  11. Musina NN, Slavkina YaS, Petrukhina DA, Zima AP, Prokhorenko TS, Saprina TV. O roli dismetabolicheskoy peregpuzki zhelezom v formirovanii nealkogol’noy zhirovoy bolezni pecheni i induktsii narusheniy uglevodnogo obmena [The role of dysmetabolic iron overload syndrome in nonalcoholic fatty liver disease and carbohydrate metabolism disorders induction]. Ozhirenie i metabolism. 2023;20(3):259-68.
  12. Loskutova EV, Vorontsova IA, Vakhitov KhM, Safiullin TR. Rol' destabilizatsii protsessov perekisnogo okisleniya lipidov i antioksidantnoy zashchity v patogeneze gipoksii u nedonoshennykh novorozhdyonnykh [The role of destabilization of lipid peroxidation processes and antioxidant protection in the pathogenesis of hypoxia in premature infants]. Kazanskiy meditsinskiy zhurnal. 2017;98(5):803-7. https://doi.org/10.17750/KMJ2017-803
  13. Narla J, Mohandas N. Red cell membrane disorders. Int J Lab Hematol. 2017;39(1):47-52.
  14. Borovskaya MK, Kuznetsova EE, Gorokhova VG, Koryakina LB, Kurilskaya TE, Pivovarov YuI. Strukturno-funktsional'naya kharakteristika membrany eritrotsita i eyo izmeneniya pri patologiyakh raznogo geneza [Structural and functional characteristics of membrane’s erythrocyte and its change at pathologies of various genesis]. Byulleten' VSNC SO RAMN. 2010;3:344-54
  15. Mohammed NA, Abd-El Rasoul HF. Evaluation of oxidative stress and antioxidant status in beta thalassemia major patients: A single-center study. Med J Cairo Univ. 2020;88(5):2147-55.
  16. Osman HG, Zahran FM, El-Sokkary AM, Sabry AM. Oxidative stress and antioxidant defense in Egyptian favism patient. Eur Rev Med Pharmacol Sci. 2013;17(9):1211-7.
  17. Ishikawa T, Nakamura Y, Sato K, Tanaka M. Oxidative stress and antioxidant levels in patients with hemolytic anemia: Focus on beta-thalassemia and sickle cell disease. Free Radical Research. 2021;55(7):650-9. https://doi. org/10.2174/156652408786241384
  18. Alegre ML, Rodriguez A, Gomez C. Evaluating oxidative stress and antioxidant markers in children with iron deficiency anemia. Pediatric Hematology and Oncology. 2022;39(2):190-8.
  19. Fernández R, Lopez J, Martin F. The role of oxidative stress in hereditary hemolytic anemias: Analysis of lipid peroxidation markers. Antioxidants. 2020;9(6):512. https://doi.org/10.3390/antiox9060512
  20. Zhao L, Chen W, Zhou Q. Oxidative stress and antioxidant response in patients with sickle cell anemia: A five-year longitudinal study. Journal of Clinical Medicine. 2019;8(4):320. https://doi.org/10.3390/jcm8040320

Authors' information:


Ismoilov Komildzhon Isroilovich,
Doctor of Medical Sciences, Full Professor, Professor of the Department of Pediatric Diseases № 2, Avicenna Tajik State Medical University
ORCID ID: 0000-0003-2431-1551
SPIN: 6703-1473
E-mail: ismoilov52@inbox.ru

Khusenova Manizha Sirodzhiddinovna,
Applicant of the Department of Pediatric Diseases № 2, Avicenna Tajik State Medical University
ORCID ID: 0000-0002-3055-9695
SPIN: 5078-5709
Author ID: 1202052
E-mail: ms.kh0595@mail.ru

Saburova Anna Mukhammadievna,
Doctor of Biological Sciences, Full Professor, Professor of the Department of Biochemistry, Avicenna Tajik State Medical University
ORCID ID: 0000-0003-3321-5019
SPIN: 9132-9748
Author ID: 425954
E-mail: Saburova-1939@mail.ru

Nasyrdzhоnova Khursand Rakhimovna,
Candidate of Biological Sciences, Associate Professor, Associate Professor of the Department of Biochemistry, Avicenna Tajik State Medical University
ORCID ID: 0000-0002-5914-8806
SPIN-код: 9872-3549
Author ID: 240263
E-mail: n_hursand@mail.ru

Information about support in the form of grants, equipment, medications

The authors did not receive financial support from manufacturers of medicines and medical equipment

Conflicts of interest: No conflict

Address for correspondence:


Khusenova Manizha Sirodzhiddinovna
Applicant of the Department of Pediatric Diseases № 2, Avicenna Tajik State Medical University

734026, Republic of Tajikistan, Dushanbe, Sino str, 29-31

Tel.: +992 (918) 836969

E-mail: ms.kh0595@mail.ru


This work is licensed under a Creative Commons Attribution 4.0 International License.

Materials on the topic: